ResearcherCentral South UniversityNo recent work listed
Can Liu
Matched on ORCID iD 0000-0001-5400-1242; OpenAlex author ID A5100447860. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2019: 1 paper · 2020: 1 paper
Papers 2
- Inhibition of LONP1 protects against erastin-induced ferroptosis in Pancreatic ductal adenocarcinoma PANC1 cells. First author DOI 10.1016/j.bbrc.2019.11.187↗
- Inhibition of LONP1 Suppresses Pancreatic Cancer Progression Via c-Jun N-Terminal Kinase Pathway-Meditated Epithelial-Mesenchymal Transition. Co-author DOI 10.1097/mpa.0000000000001321↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yong Zhou · 2 shared papers, 2019–2020 · strength 0.20
- Paper Inhibition of LONP1 protects against erastin-induced ferroptosis in Pancreatic ductal adenocarcinoma PANC1 cells. DOI 10.1016/j.bbrc.2019.11.187↗
- Paper Inhibition of LONP1 Suppresses Pancreatic Cancer Progression Via c-Jun N-Terminal Kinase Pathway-Meditated Epithelial-M… DOI 10.1097/mpa.0000000000001321↗
- Hai Wang · 2 shared papers, 2019–2020 · strength 0.20
- Paper Inhibition of LONP1 protects against erastin-induced ferroptosis in Pancreatic ductal adenocarcinoma PANC1 cells. DOI 10.1016/j.bbrc.2019.11.187↗
- Paper Inhibition of LONP1 Suppresses Pancreatic Cancer Progression Via c-Jun N-Terminal Kinase Pathway-Meditated Epithelial-M… DOI 10.1097/mpa.0000000000001321↗
- Ge Gao · 2 shared papers, 2019–2020 · strength 0.20
- Paper Inhibition of LONP1 protects against erastin-induced ferroptosis in Pancreatic ductal adenocarcinoma PANC1 cells. DOI 10.1016/j.bbrc.2019.11.187↗
- Paper Inhibition of LONP1 Suppresses Pancreatic Cancer Progression Via c-Jun N-Terminal Kinase Pathway-Meditated Epithelial-M… DOI 10.1097/mpa.0000000000001321↗
- Xiang Wu · 1 shared paper, 2019 · strength 0.09
- Gary Guishan Xiao · 1 shared paper, 2019 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.